PEG 3350 AND ELECTROLYTES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Peg 3350 And Electrolytes, and what generic alternatives are available?
Peg 3350 And Electrolytes is a drug marketed by Mylan and Novel Labs Inc and is included in three NDAs.
The generic ingredient in PEG 3350 AND ELECTROLYTES is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PEG 3350 AND ELECTROLYTES?
- What are the global sales for PEG 3350 AND ELECTROLYTES?
- What is Average Wholesale Price for PEG 3350 AND ELECTROLYTES?
Summary for PEG 3350 AND ELECTROLYTES
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Clinical Trials: | 442 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PEG 3350 AND ELECTROLYTES at DailyMed |
![PEG 3350 AND ELECTROLYTES drug patent expirations Drug patent expirations by year for PEG 3350 AND ELECTROLYTES](/p/graph/s/t/PEG_3350_AND_ELECTROLYTES-patent-expirations.png)
Recent Clinical Trials for PEG 3350 AND ELECTROLYTES
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Helwan University | N/A |
Ain Shams University | Phase 3 |
Arab Contractors Medical Centre | Phase 4 |
Pharmacology for PEG 3350 AND ELECTROLYTES
Drug Class | Osmotic Laxative Potassium Salt |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption Stimulation Large Intestine Fluid/Electrolyte Secretion |